Aethlon Medical Inc (AEMD)

[Murph1953]

This just posted on CTSO board. Relevant to AEMD? You bet. check it out.

As of November 16, 2017
***********************
H.R. 2810: National Defense Authorization Act

H.R. 2810: National Defense Authorization Act for Fiscal Year 2018
This bill was passed yesterday by Congress on November 16, 2017 and goes to the President next for signing. It contains the following provision which may have some implications for Cytosorbents considering the number of military applications they have were awarded to work on the past several years with the U.S. Department of Defense, including, the Defense Advanced Research Projects Agency, or DARPA, the U.S. Army, U.S. Special Operations Command, and the Joint Program Executive Office for Chemical Biologic Defense.

If you download the PDF of the Bill S.2810 it is there on page 156 and is now SEC.716 (changed from SEC. 732)

Quote:
SEC. 716. ADDITIONAL EMERGENCY USES FOR MEDICAL PRODUCTS
TO REDUCE DEATHS AND SEVERITY OF INJURIES CAUSED
BY AGENTS OF WAR.
Section 1107a of title 10, United States Code, is amended
by adding at the end the following new subsection:
‘‘(d) ADDITIONAL AUTHORITY TO REDUCE DEATHS AND SEVERITY
OF INJURIES CAUSED BY AGENTS OF WAR.—(1) In a case in which
an emergency use of an unapproved product or an emergency
unapproved use of an approved product cannot be authorized under
section 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C.
360bbb–3) because the emergency does not involve an actual or
threatened attack with a biological, chemical, radiological, or
nuclear agent or agents, the Secretary of Defense may authorize
an emergency use outside the United States of the product to
reduce the number of deaths or the severity of harm to members
of the armed forces (or individuals associated with deployed members
of the armed forces) caused by a risk or agent of war.